SCHEMBL30251968

SCHEMBL30251968

CC(C)c1nc(OC2CC(C(=O)O)C2)c2cc3[nH]ncc3cc2c1-c1ccc(F)cc1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.34
CTNNB1 P35222 1/20 0.33
WNT3A P56704 1/20 0.33
ROCK1 Q13464 7/20 0.33
RPS6KB1 P23443 3/20 0.33
RPS6KA1 Q15418 3/20 0.33
GRK2 P25098 1/20 0.33
GRK5 P34947 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
GCGR P47871 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
MKNK1 Q9BUB5 2/20 0.32
SGK1 O00141 2/20 0.32
GRIA1 P42261 1/20 0.32
HMGCR P04035 1/20 0.31
MET P08581 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23884510 1.00 MAPK1 (0.34) MAPK1CTNNB1WNT3AROCK1RPS6KB1
SCHEMBL23905473 1.00 MAPK1 (0.34) MAPK1CTNNB1WNT3AROCK1RPS6KB1
SCHEMBL23906103 0.92 DGAT1 (0.39) MAPK1CTNNB1WNT3AROCK1RPS6KB1
SCHEMBL23905499 0.91 GRIA1 (0.34) GCGRSGK1GRIA1
SCHEMBL30251613 0.91 GRIA1 (0.34) GCGRSGK1GRIA1
SCHEMBL23884765 0.91 GRIA1 (0.34) GCGRSGK1GRIA1
SCHEMBL25474974 0.90 ROCK1 (0.34) MAPK1CTNNB1WNT3AROCK1RPS6KB1
SCHEMBL23884660 0.89 MAPK1 (0.35) MAPK1ROCK1RPS6KB1RPS6KA1GRK2
SCHEMBL23906055 0.89 MAPK1 (0.35) MAPK1ROCK1RPS6KB1RPS6KA1GRK2
SCHEMBL30252034 0.89 MAPK1 (0.35) MAPK1ROCK1RPS6KB1RPS6KA1GRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115715292-A 1H-pyrazolo [4,3-g ] isoquinoline and 1H-pyrazolo [4,3-g ] quinoline derivatives as alpha-1-antitrypsin modulators for the treatment of alpha-1-antitrypsin deficiency (AATD) 弗特克斯药品有限公司 2023-02-24 CN disclosed